STOCK TITAN

[Form 4] Powell Industries Inc Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Cardinal Health, Inc. (CAH) filed a Form 4 indicating that Chief Executive Officer Jason M. Hollar had 5,821 common shares automatically withheld on 06/30/2025 to cover tax obligations arising from the deferred settlement of previously awarded performance share units (transaction code “F”). The price recorded for the withholding was $167.18 per share, representing an aggregate value of roughly $0.97 million. After the transaction, Hollar’s direct ownership stands at 191,815 shares.

This is an administrative, non-open-market transaction. No shares were purchased or sold for investment purposes, and there is no indication of a change in the CEO’s long-term stake. The filing therefore carries minimal fundamental or market impact, serving primarily to update compliance records under Section 16(a).

Cardinal Health, Inc. (CAH) ha presentato un Modulo 4 segnalando che l'Amministratore Delegato Jason M. Hollar ha avuto 5.821 azioni ordinarie trattenute automaticamente il 30/06/2025 per coprire obblighi fiscali derivanti dalla liquidazione differita di unità azionarie di performance precedentemente assegnate (codice transazione “F”). Il prezzo registrato per la trattenuta è stato di 167,18 $ per azione, per un valore complessivo di circa 0,97 milioni di $. Dopo la transazione, la proprietà diretta di Hollar ammonta a 191.815 azioni.

Si tratta di una transazione amministrativa, non di mercato aperto. Non sono state acquistate né vendute azioni a fini di investimento, e non vi è alcuna indicazione di un cambiamento nella partecipazione a lungo termine del CEO. La comunicazione ha quindi un impatto fondamentale o di mercato minimo, servendo principalmente ad aggiornare i registri di conformità ai sensi della Sezione 16(a).

Cardinal Health, Inc. (CAH) presentó un Formulario 4 indicando que el Director Ejecutivo Jason M. Hollar tuvo 5,821 acciones comunes retenidas automáticamente el 30/06/2025 para cubrir obligaciones fiscales derivadas de la liquidación diferida de unidades de acciones de rendimiento previamente otorgadas (código de transacción “F”). El precio registrado para la retención fue de 167,18 $ por acción, representando un valor total de aproximadamente 0,97 millones de $. Tras la transacción, la propiedad directa de Hollar es de 191,815 acciones.

Esta es una transacción administrativa, fuera del mercado abierto. No se compraron ni vendieron acciones con fines de inversión, y no hay indicios de un cambio en la participación a largo plazo del CEO. Por lo tanto, la presentación tiene un impacto fundamental o de mercado mínimo, sirviendo principalmente para actualizar los registros de cumplimiento conforme a la Sección 16(a).

Cardinal Health, Inc. (CAH)는 최고경영자 Jason M. Hollar가 2025년 6월 30일에 이전에 부여된 성과 주식 단위의 이연 결제에 따른 세금 의무를 충당하기 위해 5,821 보통주를 자동으로 원천징수했다는 내용을 양식 4에 제출했습니다(거래 코드 “F”). 원천징수 가격은 주당 167.18달러로 기록되었으며, 총 가치는 약 97만 달러에 달합니다. 거래 후 Hollar의 직접 소유 주식 수는 191,815주입니다.

이는 행정적이며, 공개 시장 거래가 아닌 거래입니다. 투자 목적의 주식 매매는 없었으며, CEO의 장기 지분 변동에 대한 징후도 없습니다. 따라서 이 제출은 기본적 또는 시장 영향이 최소한하며, 주로 섹션 16(a)에 따른 준수 기록을 갱신하는 데 목적이 있습니다.

Cardinal Health, Inc. (CAH) a déposé un Formulaire 4 indiquant que le Directeur Général Jason M. Hollar a eu 5 821 actions ordinaires automatiquement retenues le 30/06/2025 pour couvrir des obligations fiscales découlant du règlement différé d’unités d’actions de performance précédemment attribuées (code de transaction « F »). Le prix enregistré pour la retenue était de 167,18 $ par action, représentant une valeur globale d’environ 0,97 million de $. Après la transaction, la détention directe de Hollar s’élève à 191 815 actions.

Il s’agit d’une transaction administrative, hors marché ouvert. Aucune action n’a été achetée ou vendue à des fins d’investissement, et il n’y a aucune indication d’un changement dans la participation à long terme du PDG. Le dépôt a donc un impact fondamental ou de marché minimal, servant principalement à mettre à jour les registres de conformité conformément à la Section 16(a).

Cardinal Health, Inc. (CAH) reichte ein Formular 4 ein, das angibt, dass der Geschäftsführer Jason M. Hollar am 30.06.2025 automatisch 5.821 Stammaktien einbehalten ließ, um Steuerverpflichtungen aus der aufgeschobenen Abwicklung zuvor gewährter Performance-Aktieneinheiten zu erfüllen (Transaktionscode „F“). Der für die Einbehaltung verzeichnete Preis betrug 167,18 $ pro Aktie, was einem Gesamtwert von etwa 0,97 Millionen $ entspricht. Nach der Transaktion hält Hollar direkt 191.815 Aktien.

Dies ist eine administrative, nicht am offenen Markt durchgeführte Transaktion. Es wurden keine Aktien zu Investitionszwecken gekauft oder verkauft, und es gibt keine Anzeichen für eine Änderung der langfristigen Beteiligung des CEO. Die Meldung hat daher minimale fundamentale oder marktbezogene Auswirkungen und dient hauptsächlich der Aktualisierung der Compliance-Aufzeichnungen gemäß Abschnitt 16(a).

Positive
  • None.
Negative
  • None.

Insights

TL;DR Routine tax-withholding; CEO still holds ~192k shares—little investment signal.

The Form 4 shows a standard Rule 10b5-1 tax-withholding event. Code “F” denotes shares withheld to satisfy statutory taxes when performance units convert to stock, so no discretionary sale occurred. While the $0.97 million figure may seem large, the CEO retains a sizable equity position worth roughly $32 million at the transaction price, maintaining alignment with shareholders. Because it is not an open-market disposition, historical data suggest such moves have negligible correlation with future price performance. Impact on valuation multiples, earnings outlook, or capital-allocation policy is nil.

Cardinal Health, Inc. (CAH) ha presentato un Modulo 4 segnalando che l'Amministratore Delegato Jason M. Hollar ha avuto 5.821 azioni ordinarie trattenute automaticamente il 30/06/2025 per coprire obblighi fiscali derivanti dalla liquidazione differita di unità azionarie di performance precedentemente assegnate (codice transazione “F”). Il prezzo registrato per la trattenuta è stato di 167,18 $ per azione, per un valore complessivo di circa 0,97 milioni di $. Dopo la transazione, la proprietà diretta di Hollar ammonta a 191.815 azioni.

Si tratta di una transazione amministrativa, non di mercato aperto. Non sono state acquistate né vendute azioni a fini di investimento, e non vi è alcuna indicazione di un cambiamento nella partecipazione a lungo termine del CEO. La comunicazione ha quindi un impatto fondamentale o di mercato minimo, servendo principalmente ad aggiornare i registri di conformità ai sensi della Sezione 16(a).

Cardinal Health, Inc. (CAH) presentó un Formulario 4 indicando que el Director Ejecutivo Jason M. Hollar tuvo 5,821 acciones comunes retenidas automáticamente el 30/06/2025 para cubrir obligaciones fiscales derivadas de la liquidación diferida de unidades de acciones de rendimiento previamente otorgadas (código de transacción “F”). El precio registrado para la retención fue de 167,18 $ por acción, representando un valor total de aproximadamente 0,97 millones de $. Tras la transacción, la propiedad directa de Hollar es de 191,815 acciones.

Esta es una transacción administrativa, fuera del mercado abierto. No se compraron ni vendieron acciones con fines de inversión, y no hay indicios de un cambio en la participación a largo plazo del CEO. Por lo tanto, la presentación tiene un impacto fundamental o de mercado mínimo, sirviendo principalmente para actualizar los registros de cumplimiento conforme a la Sección 16(a).

Cardinal Health, Inc. (CAH)는 최고경영자 Jason M. Hollar가 2025년 6월 30일에 이전에 부여된 성과 주식 단위의 이연 결제에 따른 세금 의무를 충당하기 위해 5,821 보통주를 자동으로 원천징수했다는 내용을 양식 4에 제출했습니다(거래 코드 “F”). 원천징수 가격은 주당 167.18달러로 기록되었으며, 총 가치는 약 97만 달러에 달합니다. 거래 후 Hollar의 직접 소유 주식 수는 191,815주입니다.

이는 행정적이며, 공개 시장 거래가 아닌 거래입니다. 투자 목적의 주식 매매는 없었으며, CEO의 장기 지분 변동에 대한 징후도 없습니다. 따라서 이 제출은 기본적 또는 시장 영향이 최소한하며, 주로 섹션 16(a)에 따른 준수 기록을 갱신하는 데 목적이 있습니다.

Cardinal Health, Inc. (CAH) a déposé un Formulaire 4 indiquant que le Directeur Général Jason M. Hollar a eu 5 821 actions ordinaires automatiquement retenues le 30/06/2025 pour couvrir des obligations fiscales découlant du règlement différé d’unités d’actions de performance précédemment attribuées (code de transaction « F »). Le prix enregistré pour la retenue était de 167,18 $ par action, représentant une valeur globale d’environ 0,97 million de $. Après la transaction, la détention directe de Hollar s’élève à 191 815 actions.

Il s’agit d’une transaction administrative, hors marché ouvert. Aucune action n’a été achetée ou vendue à des fins d’investissement, et il n’y a aucune indication d’un changement dans la participation à long terme du PDG. Le dépôt a donc un impact fondamental ou de marché minimal, servant principalement à mettre à jour les registres de conformité conformément à la Section 16(a).

Cardinal Health, Inc. (CAH) reichte ein Formular 4 ein, das angibt, dass der Geschäftsführer Jason M. Hollar am 30.06.2025 automatisch 5.821 Stammaktien einbehalten ließ, um Steuerverpflichtungen aus der aufgeschobenen Abwicklung zuvor gewährter Performance-Aktieneinheiten zu erfüllen (Transaktionscode „F“). Der für die Einbehaltung verzeichnete Preis betrug 167,18 $ pro Aktie, was einem Gesamtwert von etwa 0,97 Millionen $ entspricht. Nach der Transaktion hält Hollar direkt 191.815 Aktien.

Dies ist eine administrative, nicht am offenen Markt durchgeführte Transaktion. Es wurden keine Aktien zu Investitionszwecken gekauft oder verkauft, und es gibt keine Anzeichen für eine Änderung der langfristigen Beteiligung des CEO. Die Meldung hat daher minimale fundamentale oder marktbezogene Auswirkungen und dient hauptsächlich der Aktualisierung der Compliance-Aufzeichnungen gemäß Abschnitt 16(a).

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
COPE BRETT ALAN

(Last) (First) (Middle)
8550 MOSLEY ROAD

(Street)
HOUSTON TX 77075

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
POWELL INDUSTRIES INC [ POWL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/26/2025 06/26/2025 S 3,099(1) D $200.06(2) 154,246(3) D
Common Stock 06/27/2025 06/27/2025 S 144(1) D $202.95 154,102(3) D
Common Stock 06/27/2025 06/27/2025 S 976(1) D $204.74(4) 153,126(3) D
Common Stock 06/27/2025 06/27/2025 S 348(1) D $205.63(5) 152,778(3) D
Common Stock 06/27/2025 06/27/2025 S 108(1) D $206.48(6) 152,670(3) D
Common Stock 06/27/2025 06/27/2025 S 306(1) D $207.81(7) 152,364(3) D
Common Stock 06/27/2025 06/27/2025 S 276(1) D $209.01(8) 152,088(3) D
Common Stock 06/27/2025 06/27/2025 S 843(1) D $209.94(9) 151,245(3) D
Common Stock 06/27/2025 06/27/2025 S 395(1) D $211.13(10) 150,850(3) D
Common Stock 06/27/2025 06/27/2025 S 1,659(1) D $212.72(11) 149,191(3) D
Common Stock 06/27/2025 06/27/2025 S 555(1) D $213.72(12) 148,636(3) D
Common Stock 06/27/2025 06/27/2025 S 908(1) D $214.57(13) 147,728(3) D
Common Stock 06/27/2025 06/27/2025 S 162(1) D $215.76(14) 147,566(3) D
Common Stock 06/27/2025 06/27/2025 S 95(1) D $216.82(15) 147,471(3) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2024.
2. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $200.00-200.20, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
3. Includes shares that have a time-based vesting provision.
4. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $204.22-205.01, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
5. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $205.26-206.01, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
6. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $206.28-206.75, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
7. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $207.52-208.33, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
8. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $208.53-209.35, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
9. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $209.73-210.64, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
10. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $210.84-211.50, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
11. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $212.00-213.00, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
12. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $213.01-214.01, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
13. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $214.21-214.90, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
14. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $215.35-216.00, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
15. The price reported in Column 4 is an average price; shares were sold in multiple transactions. Reporting range is $216.69-216.96, inclusive. Reporting person, upon request, will provide Powell Industries, Inc. or the staff of the Securities & Exchange Commission full information regarding the number of shares sold at each price within the ranges set for in this footnote.
Remarks:
Michael W. Metcalf, Power of Attorney for Brett A. Cope 06/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Cardinal Health (CAH) shares were involved in the CEO's Form 4 filing?

5,821 common shares were withheld to satisfy tax obligations.

What was the transaction price for the withheld CAH shares?

The shares were valued at $167.18 per share, the closing price on the prior business day.

How many CAH shares does CEO Jason M. Hollar own after the transaction?

He directly owns 191,815 shares following the withholding.

What does transaction code “F” mean in a Form 4?

Code “F” indicates shares withheld solely to pay withholding taxes; it is not an open-market sale.

Does the Form 4 suggest bullish or bearish sentiment by Cardinal Health's CEO?

Because the shares were withheld for taxes, the filing is neutral and does not signal sentiment.
Powell Inds

NASDAQ:POWL

POWL Rankings

POWL Latest News

POWL Latest SEC Filings

POWL Stock Data

2.41B
9.44M
21.84%
91.13%
14.19%
Electrical Equipment & Parts
Switchgear & Switchboard Apparatus
Link
United States
HOUSTON